rs10141326

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001099274.3(TINF2):​c.1140G>A​(p.Pro380Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0112 in 1,613,890 control chromosomes in the GnomAD database, including 1,643 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.059 ( 863 hom., cov: 32)
Exomes 𝑓: 0.0062 ( 780 hom. )

Consequence

TINF2
NM_001099274.3 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.183

Publications

5 publications found
Variant links:
Genes affected
TINF2 (HGNC:11824): (TERF1 interacting nuclear factor 2) This gene encodes one of the proteins of the shelterin, or telosome, complex which protects telomeres by allowing the cell to distinguish between telomeres and regions of DNA damage. The protein encoded by this gene is a critical part of shelterin; it interacts with the three DNA-binding proteins of the shelterin complex, and it is important for assembly of the complex. Mutations in this gene cause dyskeratosis congenita (DKC), an inherited bone marrow failure syndrome. [provided by RefSeq, Mar 2010]
TINF2 Gene-Disease associations (from GenCC):
  • dyskeratosis congenita, autosomal dominant 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, ClinGen, Ambry Genetics
  • Revesz syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
  • pulmonary fibrosis
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • dyskeratosis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hoyeraal-Hreidarsson syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • thyroid gland papillary carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001099274.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 14-24240145-C-T is Benign according to our data. Variant chr14-24240145-C-T is described in ClinVar as Benign. ClinVar VariationId is 312946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.183 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.198 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001099274.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TINF2
NM_001099274.3
MANE Select
c.1140G>Ap.Pro380Pro
synonymous
Exon 8 of 9NP_001092744.1Q9BSI4-1
TINF2
NM_001363668.2
c.1035G>Ap.Pro345Pro
synonymous
Exon 7 of 8NP_001350597.1B4DFJ1
TINF2
NM_012461.3
c.*270G>A
3_prime_UTR
Exon 6 of 6NP_036593.2Q9BSI4-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TINF2
ENST00000267415.12
TSL:1 MANE Select
c.1140G>Ap.Pro380Pro
synonymous
Exon 8 of 9ENSP00000267415.7Q9BSI4-1
TINF2
ENST00000399423.8
TSL:1
c.*270G>A
3_prime_UTR
Exon 6 of 6ENSP00000382350.4Q9BSI4-2
TINF2
ENST00000943625.1
c.1086G>Ap.Pro362Pro
synonymous
Exon 8 of 9ENSP00000613684.1

Frequencies

GnomAD3 genomes
AF:
0.0589
AC:
8944
AN:
151886
Hom.:
858
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.202
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0268
Gnomad ASJ
AF:
0.000867
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00125
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00112
Gnomad OTH
AF:
0.0459
GnomAD2 exomes
AF:
0.0150
AC:
3737
AN:
249562
AF XY:
0.0112
show subpopulations
Gnomad AFR exome
AF:
0.204
Gnomad AMR exome
AF:
0.0118
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.000167
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000856
Gnomad OTH exome
AF:
0.00874
GnomAD4 exome
AF:
0.00621
AC:
9076
AN:
1461886
Hom.:
780
Cov.:
32
AF XY:
0.00535
AC XY:
3894
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.208
AC:
6957
AN:
33478
American (AMR)
AF:
0.0128
AC:
573
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00103
AC:
27
AN:
26136
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39700
South Asian (SAS)
AF:
0.000522
AC:
45
AN:
86258
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53414
Middle Eastern (MID)
AF:
0.0139
AC:
80
AN:
5768
European-Non Finnish (NFE)
AF:
0.000460
AC:
512
AN:
1112012
Other (OTH)
AF:
0.0144
AC:
871
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
599
1198
1798
2397
2996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0590
AC:
8970
AN:
152004
Hom.:
863
Cov.:
32
AF XY:
0.0576
AC XY:
4277
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.202
AC:
8371
AN:
41418
American (AMR)
AF:
0.0268
AC:
409
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.000867
AC:
3
AN:
3462
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5156
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4800
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10592
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00112
AC:
76
AN:
67990
Other (OTH)
AF:
0.0454
AC:
96
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
366
732
1097
1463
1829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0319
Hom.:
305
Bravo
AF:
0.0668
Asia WGS
AF:
0.0250
AC:
86
AN:
3478
EpiCase
AF:
0.00136
EpiControl
AF:
0.00101

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Dyskeratosis congenita (1)
-
-
1
Dyskeratosis congenita, autosomal dominant 3 (1)
-
-
1
Revesz syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
9.6
DANN
Benign
0.65
PhyloP100
0.18
PromoterAI
0.0020
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10141326;
hg19: chr14-24709351;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.